Fig. 2

The profile of receptors and adhesion molecules on isolated NK cells in controls, moderate and severe CFS/ME participants. a Profile of CD2⁺, CD18⁺CD2⁺ and CD18⁺CD11c⁻ adhesion molecules on CD56^dimCD16⁻ NK cells in control, moderate and severe CFS/ME patients. b CD56^brightCD16^dim NK cell expression in control, moderate and severe CFS/ME patients, represented as percentage of NK cells. c Total NK cells expressing the SLAM receptor in control, moderate CFS/ME and severe CFS/ME patients. All data are represented as percentage of total NK cells (%) and shown as mean ± SEM. *represents results that were significantly different where p <0.05. NK: natural killer; CFS/ME: Chronic Fatigue Syndrome/Myalgic Encephalomyelitis; SLAM: signalling lymphocyte activation molecule; SEM: Standard Error of the Mean